{"id":"antithrombotic-agents","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal bleeding"},{"rate":"null","effect":"Major bleeding"},{"rate":"null","effect":"Thrombocytopenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They do this by targeting various molecular pathways involved in platelet activation and blood coagulation. This can help prevent conditions such as heart attacks and strokes.","oneSentence":"Antithrombotic agents work by inhibiting platelet aggregation and preventing blood clots.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:56:53.882Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Acute coronary syndrome"},{"name":"Deep vein thrombosis and pulmonary embolism"}]},"trialDetails":[{"nctId":"NCT05907694","phase":"NA","title":"Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure","status":"RECRUITING","sponsor":"Josep Rodes-Cabau","startDate":"2024-06-18","conditions":"Patent Foramen Ovale, Cryptogenic Stroke, Older Patients","enrollment":714},{"nctId":"NCT04790370","phase":"PHASE4","title":"Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Scientific Corporation","startDate":"2021-08-02","conditions":"Pulmonary Embolism","enrollment":544},{"nctId":"NCT07471256","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Minimally Invasive Puncture With Tenecteplase for Acute Lobar Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-31","conditions":"Intracerebral Hemorrhage Lobar","enrollment":636},{"nctId":"NCT07452991","phase":"NA","title":"ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2024-09-10","conditions":"Pulmonary Embolism (PE)","enrollment":300},{"nctId":"NCT06990867","phase":"PHASE2, PHASE3","title":"Optimizing Reperfusion to Improve Outcomes and Neurologic Function","status":"RECRUITING","sponsor":"Corxel Pharmaceuticals","startDate":"2025-05-15","conditions":"Acute Ischemic Stroke","enrollment":740},{"nctId":"NCT07187687","phase":"NA","title":"TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-10-24","conditions":"Intracerebral Hemorrhage","enrollment":750},{"nctId":"NCT06975969","phase":"","title":"Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter","status":"WITHDRAWN","sponsor":"Liquet Medical Inc.","startDate":"2025-09-05","conditions":"Blood Clots, Vascular Disease, Embolism Thrombosis","enrollment":""},{"nctId":"NCT07430917","phase":"PHASE2","title":"Safety and Efficacy of J147 in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Abrexa Pharmaceuticals, Inc.","startDate":"2026-03-20","conditions":"Acute Ischemic Stroke","enrollment":196},{"nctId":"NCT06241677","phase":"NA","title":"Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-04-15","conditions":"CVA (Cerebrovascular Accident)","enrollment":260},{"nctId":"NCT07424378","phase":"PHASE4","title":"Epoprostenol Plus Conventional Therapy in COld and Frostbite Injury (ECCO)","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02","conditions":"Frostbite","enrollment":66},{"nctId":"NCT07411079","phase":"","title":"Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Intracerebral Hemorrhage, Hemorrhagic Risk Conditions, Bleeding Disorders","enrollment":1126},{"nctId":"NCT05193019","phase":"","title":"Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación EPIC","startDate":"2022-03-14","conditions":"Ischemic Heart Disease, Acute Coronary Syndrome","enrollment":717},{"nctId":"NCT07389460","phase":"PHASE3","title":"Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":820},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT07084051","phase":"NA","title":"Improve Medication Adherence Among Stroke Survivors in Rural Kentucky","status":"COMPLETED","sponsor":"Hend Mansoor","startDate":"2025-07-24","conditions":"Stroke (CVA) or Transient Ischemic Attack","enrollment":4},{"nctId":"NCT07339956","phase":"EARLY_PHASE1","title":"Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-01-10","conditions":"Gastrointestinal Bleeding","enrollment":60},{"nctId":"NCT06949228","phase":"PHASE2, PHASE3","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial","status":"RECRUITING","sponsor":"ProMedica Health System","startDate":"2025-07-30","conditions":"Ischemic Stroke, Acute Disease","enrollment":132},{"nctId":"NCT07271342","phase":"","title":"Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-11-30","conditions":"Stroke","enrollment":10000},{"nctId":"NCT00147316","phase":"PHASE3","title":"Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2002-04","conditions":"Cerebral Infarction, Brain Ischemia","enrollment":103},{"nctId":"NCT06994975","phase":"PHASE3","title":"CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-03","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT07241130","phase":"","title":"Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-02-01","conditions":"Pulmonary Embolism Acute","enrollment":120},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT03263117","phase":"PHASE4","title":"SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-07-01","conditions":"Stroke","enrollment":260},{"nctId":"NCT05111613","phase":"NA","title":"The PEERLESS Study","status":"COMPLETED","sponsor":"Inari Medical","startDate":"2022-02-14","conditions":"Pulmonary Embolism, Pulmonary Thromboembolism","enrollment":692},{"nctId":"NCT07211854","phase":"","title":"Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms","status":"COMPLETED","sponsor":"Franck Assayag","startDate":"2024-09-06","conditions":"Coronary Artery Dilatations and Aneursyms","enrollment":51},{"nctId":"NCT07208695","phase":"","title":"Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2025-10-01","conditions":"Oral Antiplatele, Anticoagulant Drugs, Lower Extremity Varicose Veins","enrollment":40},{"nctId":"NCT03957707","phase":"NA","title":"Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-01-01","conditions":"Basal Ganglia Haematoma","enrollment":380},{"nctId":"NCT03335839","phase":"PHASE3","title":"Adjunctive, Low-dose tPA in Primary PCI for STEMI","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-04-01","conditions":"Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":210},{"nctId":"NCT07160491","phase":"NA","title":"Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI","status":"RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2025-09-08","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":3356},{"nctId":"NCT06320431","phase":"PHASE3","title":"ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-09-26","conditions":"Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic","enrollment":4000},{"nctId":"NCT05797792","phase":"PHASE3","title":"CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-11-18","conditions":"Stroke, Acute Ischemic, Stroke, Acute","enrollment":440},{"nctId":"NCT07151755","phase":"NA","title":"Microneedle Intra-Arterial Injection for Retinal Artery Occlusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Central Retinal Artery Occlusion","enrollment":24},{"nctId":"NCT06878066","phase":"PHASE3","title":"Thrombolysis in Factor Xa-inhibitors Trial","status":"RECRUITING","sponsor":"Guri Hagberg","startDate":"2025-03-14","conditions":"Stroke, Stroke (in Patients With Atrial Fibrillation), Ischemic Stroke","enrollment":300},{"nctId":"NCT07146360","phase":"PHASE3","title":"Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"AO GENERIUM","startDate":"2014-05-25","conditions":"Myocardial Infarction (MI)","enrollment":180},{"nctId":"NCT07139639","phase":"EARLY_PHASE1","title":"Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease","status":"NOT_YET_RECRUITING","sponsor":"Zheng Liu","startDate":"2025-11-01","conditions":"Diabetic Lower Extremity Arterial Disease","enrollment":350},{"nctId":"NCT07119021","phase":"PHASE4","title":"Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)","status":"RECRUITING","sponsor":"Ruijun Ji","startDate":"2024-08-01","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT06052969","phase":"NA","title":"Pulse Endovascular ReperFUSION for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Euphrates Vascular, Inc.","startDate":"2023-10-01","conditions":"Acute Ischemic Stroke AIS, Cerebral Arterial Disease","enrollment":8},{"nctId":"NCT06440707","phase":"PHASE2","title":"Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-15","conditions":"Acute Ischemic Stroke","enrollment":120},{"nctId":"NCT07089030","phase":"NA","title":"Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy","status":"RECRUITING","sponsor":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","startDate":"2023-06-06","conditions":"Obscure Gastrointestinal Bleeding, Iron-Deficiency Anemia, Antithrombotic Therapy","enrollment":20},{"nctId":"NCT05892510","phase":"PHASE2, PHASE3","title":"Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2024-06-01","conditions":"Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder","enrollment":462},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT04785651","phase":"NA","title":"Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies","status":"TERMINATED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2021-02-22","conditions":"Monocompartimental Tibiofemoral Osteoarthritis, Osteoarthritis","enrollment":49},{"nctId":"NCT05077124","phase":"","title":"Safe and Timely Antithrombotic Removal (STAR) Registry","status":"RECRUITING","sponsor":"CytoSorbents, Inc","startDate":"2021-09-30","conditions":"Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical","enrollment":1000},{"nctId":"NCT07032025","phase":"EARLY_PHASE1","title":"Mechanical Thrombectomy for Acute Pulmonary Embolism","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-07-01","conditions":"Acute Pulmonary Embolism","enrollment":200},{"nctId":"NCT05622500","phase":"NA","title":"Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2022-09-03","conditions":"Chronic Venous Insufficiency, Chronic Venous Thrombosis, Iliac Vein Stenosis","enrollment":12},{"nctId":"NCT05591118","phase":"PHASE3","title":"Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-07-17","conditions":"Pulmonary Embolism","enrollment":500},{"nctId":"NCT04430569","phase":"PHASE3","title":"Pulmonary Embolism International THrOmbolysis Study-3","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-08-04","conditions":"Pulmonary Embolism","enrollment":800},{"nctId":"NCT02594813","phase":"","title":"Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents","status":"RECRUITING","sponsor":"Showa Inan General Hospital","startDate":"2015-11","conditions":"Bleeding After GI Endoscopy","enrollment":10000},{"nctId":"NCT03881345","phase":"","title":"Ongoing Registry of Treatment of Venous Thromboembolism","status":"RECRUITING","sponsor":"Medalp Private Surgery Clinic","startDate":"2019-04-01","conditions":"Deep Vein Thrombosis, Thromboses, Venous, Thrombosis Embolism","enrollment":5000},{"nctId":"NCT06868511","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-25","conditions":"Deep Intracerebral Hemorrhage (ICH)","enrollment":732},{"nctId":"NCT06434324","phase":"NA","title":"Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-03-29","conditions":"Pleural Infection","enrollment":60},{"nctId":"NCT05172934","phase":"PHASE2","title":"Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial","status":"COMPLETED","sponsor":"ProMedica Health System","startDate":"2022-03-15","conditions":"Ischemic Stroke","enrollment":20},{"nctId":"NCT04347187","phase":"","title":"REGistry of Long-term AnTithrombotic TherApy-2","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2015-01-15","conditions":"Atrial Fibrillation","enrollment":2000},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT04347200","phase":"","title":"REGistry of Long-term AnTithrombotic TherApy-1","status":"RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2015-01-15","conditions":"Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease","enrollment":2000},{"nctId":"NCT06660719","phase":"PHASE3","title":"Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care","status":"RECRUITING","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2025-02-14","conditions":"Ischemic Stroke","enrollment":852},{"nctId":"NCT06115070","phase":"PHASE4","title":"Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Thrombosis, Acute Ischemic Stroke (AIS)","enrollment":390},{"nctId":"NCT06510634","phase":"","title":"Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Stroke, Ischemic","enrollment":236},{"nctId":"NCT06814964","phase":"PHASE1","title":"rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-01","conditions":"Intraventricular Hemorrhage","enrollment":18},{"nctId":"NCT06841965","phase":"PHASE3","title":"Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06749834","phase":"PHASE3","title":"Intravenous Thrombolysis and NOAC","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-27","conditions":"Acute Ischemic Stroke","enrollment":280},{"nctId":"NCT06841978","phase":"PHASE3","title":"Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-03-01","conditions":"Stroke, Acute Ischemic Stroke","enrollment":306},{"nctId":"NCT03167281","phase":"PHASE4","title":"Early Intrapleural TPA Instillation Versus Late","status":"WITHDRAWN","sponsor":"Prisma Health-Midlands","startDate":"2017-02-17","conditions":"Tissue Plasminogen Activator","enrollment":""},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT03186729","phase":"PHASE4","title":"Study of Antithrombotic Treatment After IntraCerebral Haemorrhage","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2018-07-01","conditions":"Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation","enrollment":134},{"nctId":"NCT06812000","phase":"","title":"Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2024-04-14","conditions":"Post-stroke Seizure, Post-stroke Epilepsy, Thrombolytic (t-PA) Treatment","enrollment":199},{"nctId":"NCT02398656","phase":"PHASE3","title":"A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2015-04-01","conditions":"Stroke, Acute","enrollment":1274},{"nctId":"NCT04454788","phase":"PHASE3","title":"Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion","status":"TERMINATED","sponsor":"University of Melbourne","startDate":"2020-08-01","conditions":"Ischemic Stroke","enrollment":242},{"nctId":"NCT06738108","phase":"","title":"EKOS in Patients With Pulmonary Embolism (PE)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-12-13","conditions":"Pulmonary Embolism","enrollment":104},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT03062319","phase":"PHASE4","title":"Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis","status":"TERMINATED","sponsor":"National Hospital Organization Osaka National Hospital","startDate":"2017-04-06","conditions":"Ischemic Stroke, Atrial Fibrillation, Atherothrombosis","enrollment":321},{"nctId":"NCT04559334","phase":"NA","title":"Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients","status":"SUSPENDED","sponsor":"Boston Children's Hospital","startDate":"2020-12-21","conditions":"Central Line Complication, Central Line-associated Bloodstream Infection (CLABSI)","enrollment":15},{"nctId":"NCT03876457","phase":"NA","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-10-11","conditions":"Acute Ischemic Stroke","enrollment":352},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT06667882","phase":"NA","title":"Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests","status":"COMPLETED","sponsor":"Semmelweis University","startDate":"2021-12-17","conditions":"Pulmonary Embolism Subacute Massive, Complication of Treatment, Fibrinolysis; Hemorrhage","enrollment":33},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT02777580","phase":"PHASE4","title":"STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2017-08-01","conditions":"Myocardial Infarction","enrollment":609},{"nctId":"NCT03581877","phase":"PHASE4","title":"Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwell Health","startDate":"2019-01-28","conditions":"Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism","enrollment":31},{"nctId":"NCT03998319","phase":"PHASE3","title":"A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-10-14","conditions":"STEMI, Elevated IMR (>32)","enrollment":445},{"nctId":"NCT06007222","phase":"PHASE4","title":"Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial","status":"RECRUITING","sponsor":"OCEAN-SHD Study Group","startDate":"2023-04-06","conditions":"Aortic Stenosis, TAVI(Transcatheter Aortic Valve Implantation), Aspirin","enrollment":400},{"nctId":"NCT05151172","phase":"NA","title":"EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Michael D Hill","startDate":"2022-04-15","conditions":"Acute Ischemic Stroke","enrollment":530},{"nctId":"NCT06034847","phase":"NA","title":"Treatment of Persistent Distal Occlusion After Successful Proximal Recanalization in Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2024-09","conditions":"Stroke, Acute Thrombotic","enrollment":300},{"nctId":"NCT06549582","phase":"NA","title":"Th Tl Xb Prescription on Reprogramming of Lipid Metabolism and Endothelial Injury for Cerebral Infarction Patients","status":"NOT_YET_RECRUITING","sponsor":"Yan Zhu","startDate":"2024-10","conditions":"Cerebral Infarction, Chinese Herbal Medicine, Clinical Trial","enrollment":160},{"nctId":"NCT06498323","phase":"PHASE4","title":"Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2022-08-03","conditions":"Intravenous, Thrombosis, Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT06495671","phase":"NA","title":"Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"University of Melbourne","startDate":"2024-08-01","conditions":"Ischemic Stroke, Stroke","enrollment":30},{"nctId":"NCT06487052","phase":"NA","title":"Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2024-01-10","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT05203224","phase":"PHASE2","title":"Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2022-02-18","conditions":"Ischemic Stroke","enrollment":300},{"nctId":"NCT05735301","phase":"NA","title":"Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-01-01","conditions":"Endovascular Thrombectomy","enrollment":352},{"nctId":"NCT03785678","phase":"PHASE3","title":"Tenecteplase in Stroke Patients Between 4.5 and 24 Hours","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2019-03-02","conditions":"THROMBOLYSIS","enrollment":458},{"nctId":"NCT05600816","phase":"NA","title":"SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study","status":"NOT_YET_RECRUITING","sponsor":"SurModics, Inc.","startDate":"2025-04-01","conditions":"Peripheral Vascular Occlusive Disease","enrollment":40},{"nctId":"NCT06344312","phase":"NA","title":"Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2024-01-01","conditions":"Stroke, Acute Ischemic","enrollment":60},{"nctId":"NCT05601999","phase":"PHASE3","title":"Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction","status":"RECRUITING","sponsor":"AO GENERIUM","startDate":"2021-09-03","conditions":"ST Elevation Myocardial Infarction","enrollment":244},{"nctId":"NCT05586022","phase":"","title":"Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2022-10-20","conditions":"Peripheral Arterial Occlusive Disease","enrollment":500},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT05675774","phase":"NA","title":"DECT for Differentiating Intracerebral Hemorrhage From Contrast Extravasation","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-17","conditions":"Stroke, Ischemic, Tomography, X-Ray Computed","enrollment":200},{"nctId":"NCT05105633","phase":"PHASE2, PHASE3","title":"Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2021-11-29","conditions":"Basilar Artery Occlusion","enrollment":688},{"nctId":"NCT06152939","phase":"","title":"Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Left Ventricular Thrombus","enrollment":400},{"nctId":"NCT05659160","phase":"","title":"Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2021-11-01","conditions":"Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion","enrollment":5000},{"nctId":"NCT05885178","phase":"","title":"Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-1 (TRACK-LVO-1)","status":"UNKNOWN","sponsor":"Tianjin Huanhu Hospital","startDate":"2018-01-01","conditions":"Stroke, Acute Ischemic, Endovascular Procedures, Large Vessel Occlusion","enrollment":5000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Antithrombotic agents","genericName":"Antithrombotic agents","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antithrombotic agents work by inhibiting platelet aggregation and preventing blood clots. Used for Atrial fibrillation for stroke prevention, Acute coronary syndrome, Deep vein thrombosis and pulmonary embolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}